🇺🇸 FDA
Pipeline program

VX-150

VX18-150-104

Phase 2 small_molecule completed

Quick answer

VX-150 for Acute Pain is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 2 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Acute Pain
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials